ALINAMIN-F

This brand name is authorized in Japan, Singapore.

Active ingredients

The drug ALINAMIN-F contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Fursultiamine UNII `05J61265PX` - FURSULTIAMINE
	Read more about Fursultiamine
`2`	Riboflavin UNII `TLM2976OFR` - RIBOFLAVIN
	Riboflavine is phosphorylated to flavine mononucleotide and flavine adenine dinucleotide which act as co-enzymes in the respiratory chain and in oxidative phosphorylation. Riboflavine deficiency presents with ocular symptoms, as well as lesions on the lips and at angles of the mouth.
	Read more about Riboflavin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A11EX	Vitamin B-complex, other combinations	A Alimentary tract and metabolism → A11 Vitamins → A11E Vitamin B-complex, incl. combinations
Discover more medicines within A11EX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
JP	医薬品医療機器総合機構	3122401A3025, 3122401A4021, 3122401A5028
SG	Health Sciences Authority	06298P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.